Incidence and survival of leukemias according to the different histologic subsets, in Tarragona, Spain, between 1980-1994;Incidencia y supervivencia de las leucemias según el tipo histológico en Tarragona, en el período 1980-1994

Medicina Clinica

Volumn 116, Issue 5, 2001, Pages 174-178

  González, Juan R ^a   Moreno, Víctor ^a   Borràs, Josep Maria ^a   Borràs, Joan ^b   Galceran, Jaume ^b   Grañena, Albert ^a   Bosch, Francesc Xavier ^a  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b Registro Poblacional de Cáncer de Tarragona   (Spain)

Author keywords

Hystologic types; Incidence; Leukemias; Survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLASSIFICATION; FEMALE; HUMAN; INCIDENCE; LEUKEMIA; MALE; MIDDLE AGED; REGISTER; SPAIN; SURVIVAL;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; INCIDENCE; LEUKEMIA; MALE; MIDDLE AGED; REGISTRIES; SPAIN; SURVIVAL ANALYSIS;

EID: 0035835636     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(01)71762-9     Document Type: Article

References (25)

1. Jensen OM, Esteve J, Moller H, Renard H. Cancer in the European Community and its member states. Eur J Cancer 1990; 26: 1167-1256.
2. Levi F, Mezzanotte G, Van Cong T, La Vecchia C. Cancer survival from the incident cases of the registry of Vaud, Switzerland. Tumori 1989; 75: 83-89.
3. Sriampon S, Black RJ, Sankaranarayanan R, Kamsa-ad S, Parkin DM, Vatanasapt V. Cancer survival in Khon Kaen province, Thailand. Intern J Cancer 1995; 61: 296-300.
4. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer Incidence in five continents (vol. VII). Lyon: IARC Scientific Publications, 1997; 143.
5. Groves FD, Linet MS, Devesa SS. Patterns of ocurrence of the leukaemias. Eur J Cancer. 31; 941-949.
6. Hernández JA, Land KJ, McKena RW. Leukemias, myeloma, and other lymphoreticular neoplasms. Cancer Supplement 1995; 75: 381-394.
7. Nandakumar A, Anantha N, Venupogal T, Reddy S, Padmanabhan B, Swamy K et al. Descriptive epidemology of lymphoid and haemopoietic malignances in Bangalore, India. Int J Cancer 1995; 63: 37-42.
8. Mckinney PA, Alexander FE, Cartwright RA, Scott CS, Staines A. Acute lymphoblastic leukaemia incidence in the UK by immunophenotype. Leukemia 1993; 7: 1630-1634.
9. Yavorkovsky LI, Terebkova ZF, Nikulshin SV, Yavorkovsky LL. B-chronic lymphocityc leukaemia in Latvia: epidemiological aspects. Eur J Haematol 1993;51:214-217.
10. Greaves MF, Pegram SM, Chan LC. Collaborative group study of the epidemiology of acute lymphoblastic leukaemia subtypes: background and first report. Leuk Res 1985; 9: 715-733
11. Sánchez V, Borràs JM, Mingot M. Evolución de la mortalidad por cáncer en Cataluña: 1975-1990. Med Clin (Barc) 1994; 102: 606-612.
12. Borràs JM, Borràs J, Viladiu P, Bosch FX. Epidemiologia i prevenció del càncer a Catalunya, 1975-1992 (1.a ed.). Barcelona: Institut Català d’Oncologia, 1997.
13. Registre de Mortalitat de Catalunya. Servei d’Informació i Estudis. Direcció General de Recursos Sanitaris. Departament de Sanitat i Seguretat Social, 1999.
14. Estève J, Benhamou E, Raymond L. Descriptive epidemiology. Lyon: IARC Scientific Publications, 1994; 128.
15. Web del Institut d’Estadística de Catalunya: http: //www.idescat.es
16. Holford TR. The estimation of age, period and cohort effects for vital rates. Biometrics 1983; 39: 311-324.
17. Atkin M, Andersson C, Francis B et al. Statistical modelling with GLIM. Oxford: Oxford University Press, 1989; 217-255.
18. Hakulinen T. On long-term relative survival rates. J Chron Dis 1977; 30: 431-443.
19. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Trends in cancer incidence and mortality. Lyon: IARC Scientific Publication, 1993; 121.
20. Kwiatkoski A. Trends in the incidence of leukaemia in Poland, 1963-90: an epidemiologic study. Eur J Cancer Prevent 1994; 3: 277-283.
21. Waterhouse D, Carman W J, Schottenfeld D, Gridley G, McLean S. Cancer Incidence in the rural community of Tecumseh, Michigan. Cancer 1996; 77: 763-770.
22. Gloeckler LA, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK. SEER Cancer Statistics Review, 1973-1994. Nat Inst of Health. National Cancer Institute. Información disponible en la web: http: //www-seer.ims.nci.nih.gov/Publications.
23. McNally RJQ, Roman E, Cartwrigrt RA. Leukemmias and lymphomas: time trends in the UK, 1984-93. Cancer Causes Control 1999; 10: 35-42.
24. Bennett JM, Catovsky D, Daniel MT. The French American British (FAB) co-operative group proposals for the classification of the myelodysplastic syndrome. Br J Haematol 1982; 51: 189-199.
25. Berrino F, Capocaccia R, Estève J, Gatta G, Hakulinen T, Micheli A et al. Survival of cancer patients in Europe: the EUROCARE-2 Study. Lyon: IARC Scientific Publications, 1997; 151.